http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022250465-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e9bca1120ab9d2f65b138f53e3eda4d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2022-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58e0cc781c982382cbdcd59a29e2be7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7fa8e1332abd7f1302fa3dc72c24ed6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77c3edf6de6da3292c9d7eedf1f0467d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_074ca5ba8addc2475f5210aadd6c7e4f |
| publicationDate | 2022-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2022250465-A1 |
| titleOfInvention | Novel biomarker for predicting enzalutamide resistance in prostate cancer and use thereof |
| abstract | The present invention relates to a novel biomarker for predicting resistance to enzalutamide, which is a treatment agent for castration-resistant prostate cancer, in a prostate cancer patient, and a use thereof. The present invention presents the novel biomarker that can predict enzalutamide resistance in a prostate cancer patient, and provides a composition and a kit for predicting enzalutamide resistance in a prostate cancer patient, thereby making it possible to quickly and accurately identify an individual having enzalutamide resistance at an early stage and provide appropriate treatment. |
| priorityDate | 2021-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 371.